Presentation is loading. Please wait.

Presentation is loading. Please wait.

Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax  Adalet Demir, MD, Mehmet Zeki Gunluoglu, MD, Nergiz Dagoglu, MD, Akif.

Published byBora Çoban Modified over 7 years ago

Similar presentations

Presentation on theme: "Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax  Adalet Demir, MD, Mehmet Zeki Gunluoglu, MD, Nergiz Dagoglu, MD, Akif."— Presentation transcript:

1 Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax 
Adalet Demir, MD, Mehmet Zeki Gunluoglu, MD, Nergiz Dagoglu, MD, Akif Turna, MD, FETCS, PhD, Yavuz Dizdar, MD, Kamil Kaynak, MD, FETCS, Sukru Dilege, MD, Nil Molinas Mandel, MD, Dilek Yilmazbayhan, MD, Seyyit Ibrahim Dincer, MD, Atilla Gurses, MD  Journal of Thoracic Oncology  Volume 4, Issue 2, Pages (February 2009) DOI: /JTO.0b013e318194fafe Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 A, Chest magnetic resonance image of a patient showing a thoracic mass that was confirmed to be a PNET (primitive neuroectodermal tumor). B, Chest computerized tomography image of the same patient taken after neoadjuvant chemotherapy showing total regression. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Overall survival curve of the patients who underwent surgical resection only. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Disease -free survival curve of the patients who underwent surgical resection only. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Survival curves based on tumor location. TW, Thoracic wall; TW + CVJ, Thoracic wall with costovertebral junction involvement. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 Patient survival according to the method of control: chemotherapy (±radiotherapy) and surgery (CT(±RT)+S) versus surgery (S) alone. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

7 FIGURE 6 Disease-free survival of patients according to the method of control: chemotherapy (±radiotherapy) and surgery (CT(±RT)+S) versus surgery (S) alone. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax  Adalet Demir, MD, Mehmet Zeki Gunluoglu, MD, Nergiz Dagoglu, MD, Akif."

Similar presentations

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.
Su K. Metcalfe, MD, MPH, Michael T

Su K. Metcalfe, MD, MPH, Michael T
Neoplastic Fever Caused by Lung Cancer

Neoplastic Fever Caused by Lung Cancer
Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R
The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.
Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.

Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus  Yang Zhao, MD, ZhiJun Dai,

Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus  Yang Zhao, MD, ZhiJun Dai,
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up  Marco Lucchi, MD, Franca Melfi, MD, Paolo.

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up  Marco Lucchi, MD, Franca Melfi, MD, Paolo.
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,
Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement: Anatomical versus Nonanatomical Resection  Giovanni Leuzzi, MD,

Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement: Anatomical versus Nonanatomical Resection  Giovanni Leuzzi, MD,
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer  Masatsugu Hamaji,

Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer  Masatsugu Hamaji,

Similar presentations

Ads by Google